Baxter International Inc header image

Baxter International Inc

BAX

Equity

ISIN null / Valor 911702

New York Stock Exchange, Inc (2026-05-05)
USD 16.75+0.78%

Baxter International Inc
UMushroom community rating:

star star star star star
3.00 1 votes No rating yet
NegativeNeutralPositive

About company

Baxter International Inc is a global healthcare company that focuses on hospital, nutrition, renal, and surgical care. The company provides a range of products and services, including hemostatic agents, generic injectables, parenteral nutrition systems, and dialysis therapies. Baxter BioPharma Solutions, a contract manufacturing organization, has entered into agreements with leading companies to provide manufacturing services for COVID-19 vaccines and diagnostic tests. The company's recent acquisition of Hillrom has expanded its opportunities for innovation and access to care worldwide. Baxter is committed to transforming healthcare and advancing patient care from the hospital to the home, with a focus on improving outcomes for patients with chronic conditions such as end-stage renal disease.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-45.0%1Y
-63.6%3Y
-80.7%5Y

Performance

48.0%1Y
37.2%3Y
34.1%5Y

Volatility

Market cap

8651 M

Market cap (USD)

Daily traded volume (Shares)

7,641,369

Daily traded volume (Shares)

1 day high/low

29.06 / 28.34

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.00

1 votes
Performance:
starstarstarstarstar
2.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
2.00
Tobias Kurz
Switzerland, 30 Mar 2025
star star star star star
-

EQUITIES OF THE SAME SECTOR

Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals Inc Valor: 1806798
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.07%USD 301.11
BeiGene Ltd
BeiGene Ltd BeiGene Ltd Valor: 30165310
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.12%USD 297.49
Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.84%USD 168.71
Icon PLC
Icon PLC Icon PLC Valor: 1017575
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
8.35%USD 121.32
Royalty Pharma PLC
Royalty Pharma PLC Royalty Pharma PLC Valor: 55041695
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.48%USD 50.44
Viatris Inc
Viatris Inc Viatris Inc Valor: 58198423
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.11%USD 15.52
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co Bristol-Myers Squibb Co Valor: 914188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.75%USD 56.95
Alignment Healthcare Inc
Alignment Healthcare Inc Alignment Healthcare Inc Valor: 110387702
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.98%USD 18.30
Bruker Corp
Bruker Corp Bruker Corp Valor: 1635622
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.45%USD 38.01
Masimo Corp
Masimo Corp Masimo Corp Valor: 493578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.21%USD 178.58